FDG-PET shows promise in diagnosing mesothelioma

12/3/2012 | SurvivingMesothelioma.com

A Japanese study published in Experimental and Therapeutic Medicine found that patients with malignant mesothelioma had higher FDG-PET maximum standardized uptake value compared with patients with non-malignant pleural disease. Patients with the highest SUVmax levels also had the lowest chance of long-term survival, according to the study. "Our data suggest that SUVmax levels are useful as an aid for diagnosis and prognosis of malignant pleural mesothelioma," the researchers said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA